Bellerophon Therapeutics is dedicated to bringing innovative therapies to patients and their caregivers, and partnering is at the core of our business strategy.

We are focused on establishing partnerships to build therapeutic programs of clinical and commercial value by:

• Completing the global development, launch, and commercialization of our lead product candidates INOpulse for PH-ILD, INOpulse for PH-COPD and INOpulse for PH-Sarc.

• Enhancing our pipeline of innovative product candidates targeting therapeutic areas that include cardiopulmonary disease

To discuss partnership opportunities, please Contact Us here.